Health Canada drug identification number

DIN 02246555 — REMODULIN 10 MG

REMODULIN is a solution of Treprostinil marketed by UNITED THERAPEUTICS CORPORATION. The full Treprostinil monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.

DIN
02246555
Brand name
REMODULIN
Active ingredient
Treprostinil
Strength
10 MG
Dosage form
SOLUTION
Route
INTRAVENOUS; SUBCUTANEOUS
Manufacturer
UNITED THERAPEUTICS CORPORATION
Health Canada status
MARKETED
Drug class
Prostacyclin (PGI2) analogue (vasodilator)

Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.

Other Treprostinil products

DINBrandStrengthFormManufacturerStatus
02246552 REMODULIN 1 MG SOLUTION UNITED THERAPEUTICS CORPORATION MARKETED
02246553 REMODULIN 2.5 MG SOLUTION UNITED THERAPEUTICS CORPORATION MARKETED
02246554 REMODULIN 5 MG SOLUTION UNITED THERAPEUTICS CORPORATION MARKETED

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.